Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.9 BRL | -1.92% | +3.77% | -11.73% |
07/05 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
02/05 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |
- Stock Market
- Equities
- GILD Stock
- GILD34 Stock
- News Gilead Sciences, Inc.
- Other languages